image: Studies show that an immunomodulator called fingolimod, approved for the treatment of multiple sclerosis, blocks human immunodeficiency virus (HIV) infection and infection of human immune...
For a world with a coronavirus, salvation depends on a vaccine. But in the United States, where more than 5 million people have been infected and...
Reviewed by Emily Henderson, B.Sc.July 20, 2020 Researchers at Tel Aviv University led by Professor Yaniv Assaf of the Department of Neurobiology, Biochemistry and Biophysics and...
Recent Comments